The level of expression is contrasted in various tissues, such as N-myc upregulated in solidified tumor glioma and neuroblastoma, c-Myc upregulated in solidified cancer and blood-related cancer, acting as proto-oncogene as well as transcription factor while L-myc upregulated in lung carcinoma [53]. Here, MYCN is linked to lung carcinoma.